| Ihsan Ullah 博士后 E-mail：ihsanullah@scut.edu.cn |
教育/科研工作经历
2024-至今 | 华南理工大学 | 生物医学科学与工程学院 | 博士后 |
2020-2023 | 黑龙江中医药大学生 | 药学 | 博士 |
2016-2018 | Hazara University (Pakistan) | 人类遗传学 | 哲学硕士(M.Phil) |
2012-2014 | Hazara University (Pakistan) | 生物化学 | 硕士(MSc) |
2010-2012 | University of Swat (Pakistan) | 理学学士(BSc) |
科研成果
主要从事博士研究方向为癌症代谢组学，当前重点聚焦于Nano-PROTACs在癌症免疫治疗及糖尿病创面修复中的应用研究。以第一作者/共同第一作者身份在Cancers、Frontiers in Oncology等期刊发表论文4篇。
科研方向
癌症免疫治疗与药物递送
代表性研究论文
[1] Ullah, I., Yang, L., Yin, F. T., Sun, Y.,Li, X. H., Li, J., & Wang, X. J. Multi-omics approaches in colorectal cancer screening and diagnosis, recent updates and future perspectives. Cancers, 2022, 14, 5545.
[2] Xiao, K., Li, X., Ullah, I., Hu, W., Wang, K., Yang, F. & Li, X. Unveiling the role of ASPP1 in cancer progression:pan-cancer bioinformatics and experimental validation in colorectal cancer. Frontiers in Oncology, 2025, 14, 1529809.
[3] Xiao, K., Ullah, I., Yang, F., Wang, J., Hou, C., Liu,Y. & Li, X. (2023). Comprehensive bioinformatics analysis of FXR1 across pan-cancer: Unraveling its diagnostic, prognostic, and immunological significance. Medicine, 2023, 102, e36456.
[4] Li, X., Ullah, I., Hou, C., Liu, Y.& Xiao, K. Network pharmacology and molecular docking study on the treatment of polycystic ovary syndrome with angelica sinensis-radix rehmanniae drug pair. Medicine, 2023, 102, e36118.